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Introduction
Proteostatic mechanisms are fundamental in preventing the   
accumulation of misfolded, aggregation-prone, and potentially 
cytotoxic polypeptides that are generated by mutations, tran-
scriptional and translational errors, or cellular stresses (Sherman 
and Goldberg, 2001; Arvan et al., 2002; Ellgaard and Helenius, 
2003; Powers et al., 2009). This is achieved in part by protein 
quality control (QC) mechanisms that assist folding as well   
as eliminate terminally misfolded polypeptides (Ellgaard and   
Helenius, 2001; Powers et al., 2009). Molecular chaperones, 
in conjunction with cochaperones, shield exposed hydropho-
bic residues to suppress aggregation and promote folding of 
membrane proteins in the ER lumen and cytoplasm (Young 
et al., 2004). In addition, chaperone machines are involved in 
triage  decision  by  recruiting  chaperone-dependent  ubiqui-
tination machinery to irreversibly misfolded polypeptides. 
Pioneering works have uncovered that this process culmi-
nates in the ER-associated degradation of nonnative mem-
brane proteins mediated by the ubiquitin (Ub) proteasome 
system (UPS) after the retrotranslocation of client proteins 
into  the  cytoplasm  (Brodsky  and  McCracken,  1999;  Cyr   
et al., 2002; Hampton, 2002; Ellgaard and Helenius, 2003; 
Hirsch et al., 2009).
Ubiquitination, a covalent posttranslational modification, 
is mediated by the coordinated function of the E1 Ub-activating 
enzymes and the combination of several E2 Ub-conjugating 
and hundreds of E3 Ub-ligating enzymes that confer substrate 
specificity. Ubiquitination catalyzes the attachment of either 
mono-, multiple mono–, or poly-Ub chains to client proteins 
(Hicke,  2001;  Piper  and  Luzio,  2007).  Poly-Ub  chains  are 
linked to one of the seven Lys residues on the acceptor Ub, en-
dowing distinct structural characteristics that are recognized 
by Ub-binding adaptors (Dunn and Hicke, 2001; Katzmann   
et al., 2001; Pickart, 2001; Dikic et al., 2009; Mittal and   
McMahon, 2009). Proteasome-dependent degradation of mis-
folded polypeptides is primarily mediated by K48- and K11-
linked Ub chains (Xu et al., 2009). The signal-dependent 
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ellular protein homeostasis profoundly depends 
on  the  disposal  of  terminally  damaged  poly-
peptides.  To  demonstrate  the  operation  and 
elucidate the molecular basis of quality control of con-
formationally impaired plasma membrane (PM) proteins, 
we constructed CD4 chimeras containing the wild type 
or a temperature-sensitive bacteriophage  domain in 
their  cytoplasmic  region.  Using  proteomic,  biochemi-
cal, and genetic approaches, we showed that thermal 
unfolding of the  domain at the PM provoked the re-
cruitment of Hsp40/Hsc70/Hsp90 chaperones and the 
E2–E3 complex. Mixed-chain polyubiquitination, moni-
tored  by  bioluminescence  resonance  energy  transfer 
and  immunoblotting,  is  responsible  for  the  nonnative 
chimera–accelerated internalization, impaired recycling, 
and endosomal sorting complex required for transport–
dependent lysosomal degradation. A similar paradigm 
prevails for mutant dopamine D4.4 and vasopressin V2 
receptor removal from the PM. These results outline a 
peripheral proteostatic mechanism in higher eukaryotes 
and its potential contribution to the pathogenesis of a 
subset of conformational diseases.
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Figure 1.  Unfolding induced down-regulation of CD4tl-C at the PM. (A) Schematic picture of membrane-tethered and soluble bacteriophage  model 
proteins. (B) Immunoblot (IB) analysis of CD4tl and CD4tl-/C expression before (top) or after CHX chase at 37°C for 1.5 h (bottom). Transiently transfected 
COS7 cells were cultured at 37°C or 26°C before the CHX chase. (C) Indirect immunostaining of thermally unfolded (37°C) or nativelike (26°C) CD4tl-C 555 Protein homeostasis at the cell surface • Apaja et al.
in nonpermeabilized (top) or permeabilized (bottom) COS7 cells. Calreticulin was used as an ER marker. Bars, 10 µm. (D) The PM density of chimeras 
was determined by ELISA as described in Materials and methods. (E) Pharmacological characterization of rescued and then unfolded CD4tl-C degrada-
tion as measured by CHX chase and immunoblotting. Lactacystine (LAC), concanamycin (Con), and bafilomycin A1 (Baf) were added simultaneously with 
CHX for 3.5 h. NH4Cl and chloroquin (Chl) were present during the last 2 h of the CHX chase. Equal amounts of proteins were loaded. (F and G) The PM 
stability of rescued and then unfolded model proteins at 37°C for 1.5 h was determined at 37°C (F) or in the absence of unfolding at 26°C (G) by ELISA.   
(H) Internalization of unfolded and rescued model proteins was monitored by Ab uptake at 37°C. Data are expressed as the percentage of initial Ab 
binding. (I) Recycling efficiency was determined by a biotin-streptavidin sandwich assay as described in Materials and methods and expressed as the 
percentage of CD4tl. Molecular mass is given in kilodaltons. The data shown represent means ± SEM.
 
down-regulation  and  lysosomal-associated  degradation  of 
native plasma membrane (PM) receptors, however, are pref-
erentially catalyzed by K63-linked Ub chains (Duncan et al., 
2006; Barriere et al., 2007; Varghese et al., 2008; Boname   
et al., 2010).
Integral  membrane  proteins  with  limited  conforma-
tional  defects  may  escape  the  ER  and  are  either  retrieved 
from the Golgi compartment back to the ER or targeted for 
vacuolar/lysosomal proteolysis (Cole et al., 1998; Tsigelny   
et al.,  2005; Wang  and  Ng,  2010). The  latter  process  can 
be initiated from the Golgi compartment or from the PM 
(Wolins et al., 1997; Reggiori and Pelham, 2002; Ehrlich   
et al., 2009). Although rapid elimination of mutant PM proteins 
is attributed to conformational defects, the underlying struc-
tural perturbations remain poorly defined (Ljunggren et al., 
1990; Li et al., 1999; Zaliauskiene et al., 2000; Benharouga 
et al., 2001; Gong and Chang, 2001; Sharma et al., 2001; 
Wilson et al., 2001; Fayadat and Kopito, 2003; Schaheen 
et al., 2009). Ubiquitination of a subset of membrane pro-
teins (Pma-1, bile salt export pump [BSEP], cystic fibrosis 
transmembrane  conductance  regulator  [CFTR],  and  Na/H 
exchanger [NHE6]) was proposed to play a determinant role 
in their rapid turnover at the PM (Gong and Chang, 2001; 
Sharma et al., 2004; Hayashi and Sugiyama, 2009; Roxrud 
et al., 2009). These observations, along with the discovery 
of  the  endosomal  sorting  complex  required  for  transport   
(ESCRT)–dependent lysosomal degradation of ubiquitinated 
native cargo molecules (Katzmann et al., 2001; Raiborg and 
Stenmark, 2009), led to the proposition that the peripheral 
QC system can recognize, ubiquitinate, and eliminate non-
native polypeptides from the PM or endosomes in both yeast 
and  mammalian  cells  (Arvan  et  al.,  2002;  Sharma  et  al., 
2004). The molecular machinery of peripheral QC systems, 
however, remains unknown.
To assess the molecular consequences of unfolding at 
the PM, we designed a chimeric membrane protein with a 
temperature-sensitive folding defect. Unfolding induced the 
chaperone-  and  E2–E3-dependent  polyubiquitination,  inter-
nalization,  and  ESCRT-dependent  lysosomal  destruction  of 
the chimera from the PM. Similar cellular and biochemical 
processes are involved in the mutant vasopressin V2 receptor 
(V2R) and dopamine D4.4 receptor (DRD4) disposal from the 
PM, uncovering the potential contribution of the peripheral 
QC to the pathogenesis of conformational diseases. A prelimi-
nary study of this work has been published in abstract form 
(Apaja, P., and G. Lukacs. 2009. Membrane protein quality 
control in post-Golgi compartments. Experimental Biology. 
Abstr. 668.3).
Results
PM model protein with a thermosensitive 
conformational defect
We  designed  a  monotopic  transmembrane  model  protein  to 
study the cellular and biochemical consequences of misfolding   
at the PM. The C-terminally truncated CD4 incorporating a 
flexible  cytoplasmic  linker  was  used  as  a  reporter  molecule 
(CD4tl;  Fig.  1 A)  because  it  lacks  a  specific  sorting  signal 
and is constitutively targeted to the PM (Barriere et al., 2006). 
The N-terminal DNA-binding domain of the wild type (wt) or 
L57C mutant bacteriophage  repressor was fused to the trun-
cated CD4 (CD4tl- and CD4tl-C, respectively; Fig. 1 A). The 
melting temperature (Tm) of the recombinant wt  domain was 
54°C. The Tm of the mutant containing the L57C substitution 
(C) was decreased to 32°C (Parsell and Sauer, 1989). The 
two-state unfolding profile and the reduced Tm enabled us to 
shift the conformational equilibrium of the CD4tl-C cytosolic 
domain from the largely native state at 26°C to a predominantly 
nonnative state at 37°C.
The CD4tl as well as CD4tl- and CD4tl-C were detected 
with the expected apparent molecular masses (55 and 75 kD, 
respectively) by immunoblotting with anti-CD4 antibody (Ab) 
in transiently transfected COS7 and stable Flp-In tetracycline-
inducible HEK293 cells at 26°C (Fig. 1 B and Fig. S1 A).   
Attachment of the  to the CD4tl decreased, whereas the fusion 
of the C almost completely eliminated the expression of the re-
spective chimera at 37°C (Fig. 1 B, top, lanes 2–4), suggesting 
that the mutant processing differs from the wt at the restrictive 
temperature. Indeed, the CD4tl-C was predominantly confined 
to the ER at 37°C in COS7 and HEK293 cells as visualized by 
coimmunostaining and laser confocal fluorescence microscopy 
using calreticulin and calnexin as specific ER markers (Fig. 1 C 
and not depicted). The cell surface density of the CD4tl-C was 
only 30% of the CD4tl when measured by the immunoperoxi-
dase assay with anti-CD4 primary and HRP-conjugated second-
ary Ab (Fig. 1 D and Fig. S1 B). Rescuing the C conformational 
defect at 26°C increased the CD4tl-C cellular and PM expres-
sion (Fig. 1, B–D; and Fig. S1 B).
The temperature-rescued CD4tl-C, but not the CD4tl- 
or the CD4tl expression, was eliminated upon inhibiting trans-
lation with cycloheximide (CHX) for 1.5 h at 37°C (Fig. 1 B, 
bottom, lanes 6–8). The CHX-induced disposal of CD4tl-C 
was delayed by inhibitors of the proteasome (lactacystine) and 
lysosomal proteolysis (concanamycin, bafilomycin A, NH4Cl, 
and chloroquine), suggesting that the unfolded chimera is dis-
posed  by  ER-associated  and  lysosomal  degradation  at  37°C 
(Fig. 1 E).JCB • VOLUME 191 • NUMBER 3 • 2010   556
that  the  chimera  was  predominantly  localized  to  the  PM   
(Fig. 2 C). Thermal unfolding accelerated the endocytosis rate 
of  rescued  CD4tl-C  and  CD4tl-RlucII-C  proportional  to   
the incubation time at 40°C (Fig. 2 D). The progressively in-
creasing BRET
2 signal between the CD4tl-RlucII-C and the 
GFP
2-Ub during thermal unfolding suggests that ubiquitina-
tion of the chimera accounts for its accelerated internalization   
(Fig. 2 E). Neither the positive control exchange protein di-
rectly activated by cAMP (EPAC; Ponsioen et al., 2004), the 
constitutively polyubiquitinated CD4tl-Ub (Barriere et al., 
2006), nor the GFP-UbAA (UbAA) exhibited temperature- 
dependent BRET
2 (Fig. 2, E and F). GFP-UbAA lacks the ter-
minal Gly residues of Ub that are essential for Ub conjugation 
(Coulon et al., 2008).
Endpoint measurements revealed a threefold increase in 
the BRET
2 efficiency after unfolding the CD4tl-RlucII-C, tak-
ing into consideration the nonspecific BRET
2 signal in the pres-
ence of GFP
2 (Fig. 2 F, fifth bar). Similar results were obtained 
using coelenterazine 400a or ViviRen as substrates (Fig. S2 C). 
BRET
2 efficiency was reduced to background if GFP
2-Ub or the 
CD4tl-RlucII-C was substituted with GFP
2-UbAA or CD4tl-
RlucII, respectively (Fig. 2 F). These observations jointly sug-
gest that thermal unfolding provokes the chimera ubiquitination 
at the PM and in early endosomes.
The activity of the cellular ubiquitination machinery is   
indispensable for the CD4tl-C rapid disposal from the PM.   
The mutant chimera was stabilized in ts20, but not in E36, cells 
expressing a temperature-sensitive and wt E1 Ub-activating   
enzyme, respectively (Ciechanover et al., 1991). Down-regulation 
of the E1 enzyme at 40°C delayed the PM turnover of CD4tl-C 
in ts20 cells and reduced the CD4tl-C internalization rate to the 
CD4tl level (Fig. S2, D–F) but did not interfere with CD4-
LAMP1 and transferrin (Tf) receptor (Tf-R) endocytosis sig-
naled by linear endocytic motifs (Barriere et al., 2006). These 
results suggest a causal relationship between ubiquitination and 
the PM down-regulation of unfolded CD4tl-C at 37°C.
Identification of the ubiquitination 
machinery of unfolded CD4tl-C at the  
cell surface
The molecular machinery responsible for the CD4tl-C ubiq-
uitination at the PM was identified by mass spectrometry (MS). 
Unfolded CD4tl-C protein complexes were isolated by cs-IP 
and trypsin digested, and peptide profiles were determined by 
liquid  chromatography  (LC)–MS/MS  and  database  searches 
(Cloutier et al., 2009). C-terminal Hsp70-interacting protein 
(CHIP), a cytosolic QC Ub ligase, and molecular chaper-
ones (Hsc70/Hsp70/Hsp90) were preferentially isolated in 
the CD4tl-C complex when compared with that of the CD4tl   
(Fig. S3, B and C).
cs-IP confirmed that both endogenous and heterologously 
expressed  myc-CHIP  associates  with  the  unfolded  chimera 
(Fig. 3, A and B, lane 3). CHIP was unable to bind to the native-
like CD4tl-C (26°C; Fig. 3, A and B, lane 4), CD4tl (Fig. 3,   
A [lanes 5 and 6] and B [lane 10]), or CD4tl- (Fig. 3, A [lanes 1 
and 2] and B [lane 9]), indicating that the complex formation is 
conformation sensitive at the PM.
Unfolding of the C accelerates endocytosis 
and impedes recycling of the CD4tl-C
To  assess  the  cellular  consequence  of  the  conformational   
destabilization of the C domain, the CD4tl-C turnover was 
monitored  by  the  immunoperoxidase  assay. After  thermal   
unfolding at 37°C for 1 h, the rescued CD4tl-C was elimi-
nated three times faster than its wt counterpart from the PM 
(Fig. 1 F). Consistently, CD4tl-C that constitutively reached 
the PM at 37°C exhibited a three- to fourfold accelerated turn-
over in HEK293 and COS7 cells (Fig. S1, C and D). In con-
trast, only 40% of the CD4tl-C was eliminated after 5-h 
chase at 26°C, whereas the turnover of CD4tl and CD4tl- was 
negligible (Fig. 1 G).
Changes in internalization, recycling, and lysosomal de-
livery kinetics may account for the rapid disposal of CD4tl-C 
from the PM at 37°C. Tethering the  or the C domain acceler-
ated the internalization rate of the CD4tl (2% per minute) by 
50% and 290%, respectively (Fig. 1 H and Fig. S1 E). The 
internalization of the CD4tl-C, measured by anti-CD4 Ab   
uptake at 37°C (see Materials and methods), was attenuated by 
rescuing the C conformational defect at 26°C (Fig. 1 H).
Recycling of unfolded CD4tl-C was inhibited when com-
pared with that of the CD4tl and CD4tl- (Fig. 1 I). However, 
rescuing the CD4tl-C folding defect at 26°C partially restored 
the chimera recycling at 37°C (Fig. 1 I) as determined by using 
a modified biotin-neutravidin sandwich technique as described 
in Materials and methods. These results suggest that conforma-
tion-dependent cargo sorting occurs at endosomes.
CD4tl-C unfolding provokes ubiquitination 
at the PM
To assess whether Ub conjugation serves as a signal for the   
chimera down-regulation from the PM, the chimeras were   
selectively isolated using cell surface immunoprecipitation (IP 
[cs-IP]). Anti-CD4 Ab  was  bound  to  intact  cells  at  4°C.   
Immunocomplexes were isolated using a two-step denaturing 
precipitation protocol as described in Materials and methods. 
Precipitates were probed with the P4D1 anti-Ub Ab recognizing 
K63-, K48-, and K11-linked poly-Ub chains, but not the mono-Ub. 
Densitometry revealed that the ubiquitination of the unfolded 
CD4tl-C was 8.9 ± 1.6 (means ± SEM; n = 4) times more 
augmented at 37°C than at 26°C when normalized for protein 
expression (Fig. 2 A, lanes 3 and 4). Both CD4tl and CD4tl-  
displayed  marginal  ubiquitination  (Fig.  2 A).  Isolation  of 
ubiquitinated CD4tl-C from intracellular compartments was 
ruled out because the dissociation of anti-CD4 Ab was negligi-
ble during the course of the precipitation (Fig. S2, A and B).
To provide direct evidence for unfolding-provoked ubiq-
uitination at the PM and in early endosomes, we implemented a 
bioluminescence resonance energy transfer (BRET
2) assay based 
on principles that allowed the detection of the -arrestin-2-Rluc 
ubiquitination in real time (Perroy et al., 2004). We rationalized 
that conjugation of GFP
2-Ub to unfolded CD4tl-C containing   
the Renilla luciferase II (CD4tl-RlucII-C) would enhance the 
BRET
2 efficiency (Fig. 2 B). To confine the native chimera to 
the PM, CD4tl-RlucII-C were rescued at 26°C and chased in 
the presence of CHX for 5 h. Indirect immunostaining verified 557 Protein homeostasis at the cell surface • Apaja et al.
the H260Q substitution, or deleting the U-box domain (CHIP-
U-box) significantly attenuated CHIP-myc interaction with 
the PM-resident CD4tl-C at 37°C (Fig. 3 B, lanes 5–8). These 
results suggest that chaperone-dependent CHIP recruitment is, 
at least in part, responsible for the recognition and ubiquitination 
To probe the mechanism of CHIP association with un-
folded CD4tl-C, we used three CHIP variants in concert with 
cs-IP. Preventing chaperone binding to the CHIP N-terminal 
tetratricopeptide (TPR) domain by the K30A mutation (K30A-
CHIP), inhibiting the E2 binding and the Ub ligase activity by 
Figure 2.  Unfolding initiates ubiquitination of CD4tl-C at the PM. (A) Ubiquitination of CD4 chimeras isolated by denaturing cell surface immunoprecipita-
tion (cs-IP) was measured by immunoblotting using the HRP-conjugated P4D1 anti-Ub Ab. Three times more CD4tl-C–expressing cells were harvested than 
CD4tl-–expressing cells. Molecular mass is given in kilodaltons. IB, immunoblot. (B) Approach to monitor the ubiquitination of CD4tl-RlucII-C by BRET
2  
in vivo. (C) The temperature-rescued CD4tl-RlucII-C (26°C) is largely confined to the PM and shows negligible colocalization with calreticulin. Indirect immuno-
staining was performed before and after CHX chase for 5 h at 26°C. Bars, 5 µm. (D) 26°C temperature-rescued cells were incubated for the indicated times 
at 40°C, and the internalization rates of CD4tl-C and CD4tl-RlucII-C were determined by Ab uptake at 37°C. (E) Unfolding stimulates of CD4tl-RlucII-C  
ubiquitination detected by BRET
2. HEK293 cells coexpressing rescued CD4tl-RlucII-C and GFP
2-Ub or GFP
2-UbiAA were treated with CHX for 5 h at   
26°C. BRET
2 was measured in the presence of 5 µM coelenterazine 400a. EPAC expression served as a positive control. (F) Summary of BRET
2 results of 
experiments shown in E. BRET
2 was measured on cells cultured at 26°C before or after 5-min exposure to 40°C. The dotted line indicates the background 
BRET
2 signal. epa, EPAC. The data shown represent means ± SEM.JCB • VOLUME 191 • NUMBER 3 • 2010   558
CHIP-myc in shCHIP-expressing cells (Fig. 4, E and F; and see 
Fig. 3 B for CHIP expression), substantiating the notion that 
chaperone binding and ligase activity of CHIP are required for 
the chimera down-regulation from the PM.
Poly-Ub–chain configuration of unfolded 
CD4tl-C and EGFP-C
The high molecular mass smear of CD4tl-C isolated by cs-IP 
and visualized by the P4D1 anti-Ub Ab suggested that the   
unfolded chimera is polyubiquitinated in post-Golgi compart-
ments (Fig. 2 A and Fig. 5 A). Because the P4D1 Ab recognizes 
K63-, K11-, and K48-linked Ub chains, the chain configuration 
was probed by K48 (Apu2.07) and K63 (Apu3.A8) linkage–
specific anti-Ub Abs (Newton et al., 2008). Purified K48-, K63-, 
and K11-linked oligo-Ub’s were used as standards (Fig. 5 A and 
Fig. S2, G and H). The native and unfolded chimera was iso-
lated by cs-IP from the PM (Fig. 5 A, lanes 1, 3, and 4) using   
Ab capture at 4°C or at 37°C for 1.5 h (Fig. 5 A, lane 2). The 
latter protocol isolated PM and endosomal resident chimeras.   
Because K48 and K68 anti-Ub Abs do not recognize mono-Ub 
(Fig. 5 A, lanes 7 [left] and 8 [right]), a significant fraction of 
the C was polyubiquitinated. The unfolded CD4tl-C had a 
higher content of K63- than K48-linked Ub chains based on the 
chain specificities of the Abs (Fig. 5 A, lanes 2 and 3). The for-
mation of other Ub-chain configurations, however, cannot be 
ruled out (Fig. S2, G and H).
Although all seven Ub-chain configurations can be syn-
thesized by CHIP in vitro (Xu et al., 2006), CHIP activity   
is primarily responsible for the UPS-dependent degradation 
of K48- and K11-linked polyubiquitinated proteins at the   
ER and in the cytoplasm (Kim et al., 2007; Kundrat and   
Regan, 2010). Therefore, we asked whether the degradation 
of the chimera (Connell et al., 2001; Rosser et al., 2007). This 
inference was confirmed by demonstrating the selective asso-
ciation of Hsp90/Hsp40/Hsc70/Hsp70 with unfolded CD4tl-C, 
but not with CD4tl- and CD4tl at the PM (Fig. 3 C).
CHIP-dependent polyubiquitination  
down-regulates the unfolded CD4tl-C  
from the PM
The function of CHIP in the peripheral fate of misfolded CD4tl-C 
was examined next. Overexpression of the catalytically inactive 
H260Q-CHIP, U-box CHIP, or UbcH5a delayed the CD4tl-C 
disposal from the PM but had a marginal effect on the CD4tl- 
(Fig. 4 A and Fig. S3 D). In contrast, dominant-negative Nedd-4, 
AIP4, Casitas B-lineage lymphoma (Cbl)–b, UbcH5b, and UbcH5c   
had negligible effects on the chimera turnover (Fig. 4 A and 
not depicted).
As a second approach, CHIP was ablated by stably ex-
pressing a CHIP-specific short hairpin RNA (shRNA; shCHIP) 
in HEK293 cells. CHIP depletion (Fig. 4 B) resulted in attenu-
ated ubiquitination and turnover of the CD4tl-C at the PM 
(Fig.  4,  C–E).  Similar  results  were  obtained  with  siRNA- 
mediated CHIP depletion, strongly suggesting that the CHIP 
activity accounts for the unfolded chimera turnover (Fig. S3, 
E–G). Notably, CHIP-myc overexpression destabilized CD4tl-C 
in shCHIP cells at the PM (Fig. 4, E–G). The stability and   
internalization rates of tetrameric CD4Tcc-UbAllRG and 
the Tf-R signaled by tetrameric mono-Ub (Barriere et al., 
2006)  and  Ub-independent  endocytic  motifs,  respectively, 
were unaltered, ruling out nonspecific effects of CHIP abla-
tion (Fig. 4, F and G).
Remarkably, the rapid PM turnover of the CD4tl-C could 
not be restored by overexpressing K30A, H260Q, or U-box 
Figure  3.  CHIP  and  molecular  chaperones 
are recruited to unfolded CD4tl-C at the PM. 
(A  and  B)  CHIP  associates  with  unfolded   
CD4tl-C at the PM. Native cs-IP was performed, 
and precipitates were probed with anti-CHIP 
and  anti-HA  Abs  (A).  Exogenous  CHIP-myc 
association  was  probed  in  HEK293  cells   
cotransfected with the indicated construct and 
cultured at 26°C or 37°C (B). (C) Molecular 
chaperones  associate  with  the  CD4tl-C  but   
not  with  CD4tl-  at  the  PM.  Nondenaturing   
cs-IP was performed and probed as described 
in A. Molecular mass is given in kilodaltons. 
IB, immunoblot.559 Protein homeostasis at the cell surface • Apaja et al.
Multivesicular body (MVB)/lysosomal 
targeting of unfolded CD4tl-C is  
ESCRT dependent
The recycling defect suggested that the chimera is subjected to 
conformation-dependent  postendocytic  sorting.  This  was  as-
sessed first by indirect immunostaining. Internalized chimeras 
were labeled by anti-CD4 Ab capture for 20 min and chased for 
1 h at 37°C. The CD4tl predominantly, whereas the CD4tl- 
partially, colocalized with Tf- and EEA1-positive early endo-
somes and were precluded from dextran- and LAMP2-labeled 
MVB/lysosomes (Fig. 6 A and not depicted). In contrast, un-
folded CD4tl-C was largely delivered into MVB/lysosomes 
and precluded from early endosomes (Fig. 6 A).
The lysosomal targeting of unfolded CD4tl-C was con-
firmed by measuring the luminal pH of chimera-containing ves-
icles using fluorescence ratio image analysis (FRIA). FRIA has 
been used to determine the endocytic sorting of various recep-
tors and channels (Barriere et al., 2006, 2007; Kumar et al., 
2007; Barriere and Lukacs, 2008; Duarri et al., 2008; Varghese 
et al., 2008; Glozman et al., 2009). The chimera was labeled 
pathway and the Ub-chain configuration were altered by attach-
ing the C domain to the soluble cytoplasmic EGFP (EGFP-C; 
Fig. 1 A).
The temperature-sensitive expression, stability defect, and 
polyubiquitination as well as proteasome-dependent degrada-
tion of the EGFP-C were documented (Fig. 5 B and Fig. S4, 
A–E).  As  expected,  CHIP-dependent  polyubiquitination  is 
largely responsible for the proteasome-dependent disposal of 
the unfolded EGFP-C because (a) both endogenous CHIP and 
CHIP-myc  are  coprecipitated  with  EGFP-C,  but  not  with 
EGFP- or EGFP (Fig. 5 C); and (b) CHIP depletion prevented 
both  ubiquitination  as  well  as  the  rapid  degradation  of  the 
EGFP-C (Fig. S4 F and Fig. 5 D). The EGFP-C was enriched 
in K48-linked Ub chains relative to the CD4tl-C, though   
K63-linked chains were also detected (Fig. 5 A, lanes 3 and 5).   
Likewise, the ER-retained CD4tl-C contained predominantly 
K48-linked Ub chains (unpublished data). Thus, CHIP-mediated 
polyubiquitination of unfolded C can lead to either protea-
some- or lysosome-dependent degradation as a function of the 
chimera subcellular localization.
Figure 4.  Cellular and biochemical phenotype   
of  the  CD4tl-C  upon  inactivation  of  CHIP.  
(A) Effects of dominant-negative (DN) E3 and E2 
enzymes on the PM stability of CD4tl-C were 
measured in transiently cotransfected HEK293 
cells and monitored by cell surface ELISA after 
30-min chase at 37°C. Fig. S3 D depicts the 
CD4tl- PM stability (**, P < 0.01; n = 5). The 
dotted line indicates the chimera cell surface 
turnover in mock-transfected cells. (B) CHIP ab-
lation was accomplished by lentiviral shCHIP 
in Flp-In T-Rex HEK293 cells expressing CD4tl-C   
and verified by immunoblotting. CHIP-myc over-
expression was detectable in the shCHIP cells. 
CHIP depletion had an adverse effect on tetra-
cycline transactivation, reducing the induction   
level of CD4tl-C in shCHIP cells. (C) Ubiq-
uitination level of the PM CD4tl-C was probed 
by denaturing cs-IP and immunoblotting. Three 
times more shCHIP cells were used. (D) Stabil-
ity of internalized CD4tl-C was measured by 
labeling the PM-resident chimera with anti-CD4 
Ab at 4°C and chasing for 0–1 h at 37°C in 
shNT and shCHIP cells. Ab–chimera complexes 
were precipitated and immunoblotted. (E) The 
PM  turnover  of  the  CD4tl-C  was  measured 
by cell surface ELISA in control, shCHIP, and 
CHIP-myc–transfected  cells.  (F)  The  CD4tl-C 
and  CD4cc-UbAllRG  (UbRG)  PM  stability 
was determined after 1-h chase in shCHIP cells 
coexpressing  the  CHIP-myc  variant.  (G)  The 
internalization rate of CD4tl-C was monitored 
in  the  absence  or  presence  of  CHIP-myc  at 
37°C by Ab uptake in shCHIP cells for 5 min. 
Endocytosis  of  tetrameric  CD4cc-UbAllRG 
(UbRG) and transferrin (Tf) was measured for 
2.5 min. (H) Mean vesicular pH of internalized 
cargo was determined by FRIA in small interfer-
ing NT and small interfering CHIP (siCHIP) cells 
as described in Materials and methods. Anti-
CD4 Ab and FITC-Fab were bound on ice, and 
FRIA was performed after 1-h chase at 37°C. 
NT, nontargeted siRNA. The lysosomal target-
ing of CD4tl-Ub, CD63, and dextran was not 
influenced by shCHIP. Molecular mass is given 
in kilodaltons. IB, immunoblot. The data shown 
represent means ± SEM.JCB • VOLUME 191 • NUMBER 3 • 2010   560
back to the PM at 37°C, confirming the localization and re-
cycling results (Fig. 1 I and Fig. 6 A). Rescuing the folding   
defect at 26°C led to a substantial delay in the CD4tl-C lyso-
somal delivery at 37°C (Fig. 6, B and D).
ESCRT-0 (Hrs [hepatocyte growth factor–regulated tyro-
sine kinase substrate] and Stam1 [signal-transducing adaptor 
molecule]) and ESCRT-I (TSG101 [tumor susceptibility gene 
101]) components are essential Ub-binding adaptors for ubiqui-
tinated native cargo delivery into MVB/lysosomes (Katzmann 
et al., 2001). Down-regulation of Hrs, Stam1, and TSG101 by 
si/shRNA (Fig. 6 E) delayed the unfolded CD4tl-C degrada-
tion and removal from the PM (Fig. 6 F and Fig. S3 A) and 
with anti-CD4 Ab and secondary FITC-conjugated Fab as a pH 
sensor in live cells and chased for 0–2 h. Considering that early 
and late endosomes have a luminal pH of 6.0–6.5 and 5.5–6.0, 
respectively, whereas the lysosomal pH is <5.5 (Mukherjee   
et al., 1997), localization of the chimera could be established 
based on the vesicular pH. The luminal pH of FITC-Tf–labeled en-
dosomes as well as CD4tl-Ub and dextran-loaded lysosomes were 
used as references (Fig. 6 B; Barriere and Lukacs, 2008). Repre-
sentative pH distribution patterns of CD4tl-– and CD4tl-C– 
containing vesicles are shown in Fig. 6 B with a mean pH of   
6.2 ± 0.19 and 5.2 ± 0.13, respectively. Thus, CD4tl-C is effi-
ciently targeted to MVB/lysosomes, whereas CD4tl- recycles 
Figure 5.  Unfolded CD4tl-C undergoes mixed-chain polyubiquitination at the PM. (A) Ub-chain configuration of native and unfolded CD4tl-C at the PM 
and endosomes. Denaturing cs-IP of the CD4tl-C was performed after (a) temperature rescue at 26°C (native), (b) unfolding the rescued chimera at 37°C for 
1.5 h, and (c) culturing the cells at 37°C. Anti-CD4 Ab was bound at 4°C, except in b, in which Ab labeling was performed at 37°C for 1.5 h. Precipitates 
were probed with anti-Ub Abs. Denaturing IP of EGFP-C and EGFP was accomplished with anti-EGFP Ab. Ab specificity was probed by 2 µg mono-Ub and 
0.2 µg K63- and K48-linked poly-Ub chains. Asterisks indicate nonspecific Ab reactivity. (B) Ubiquitination of soluble EGFP- and -C was detected after 
denaturing IP and immunoblotting of the cells exposed to 26°C or 37°C. (C) Association of the EGFP- and -C chimeras with endogenous and exogenous 
CHIP was examined by nondenaturing IP and immunoblotting. (D) Turnover rates of the EGFP- and -C were measured in control and shCHIP cells by CHX 
chase and immunoblotting. Molecular mass is given in kilodaltons. IB, immunoblot.561 Protein homeostasis at the cell surface • Apaja et al.
induced early endosomal retention in a compartment with a lu-
minal pH of 6.0–6.5 (Fig. 6 G). As a consequence, the chimera 
post-Golgi stability was increased, and lysosomal delivery was 
impeded in the presence of Hrs and TSG101 siRNA (Fig. 6,   
F and G). The lysosomal delivery of CD63, CD4tl-Ub, and 
dextran as well as the Tf-R recycling were preserved in siRNA-
treated cells (Fig. 6 G). Thus, Hrs, Stam1, and TSG101 have 
critical roles in the proteolytic disposal of nonnative chimeras 
from the cell surface. Accordingly, CHIP activity was indis-
pensable for the lysosomal sorting of unfolded CD4tl-C, but 
not dextran or CD63 (Fig. 4 H). Likewise, the Ub-dependent 
lysosomal targeting of the CD4tl-Ub chimera was unaltered, 
ruling out the possibility that CHIP knockdown interferes with 
the function of the Ub-dependent endosomal sorting machin-
ery nonspecifically (Fig. 4 H).
Proteolytic QC of mutant G protein–
coupled receptors (GPCRs) at the PM
To test whether the peripheral QC system is involved in the 
degradation of other conformationally defective PM proteins, 
we selected the DRD4 and the V2R. The DRD4-M345T muta-
tion is implicated in attention deficit hyperactivity disorder, 
and the V2R-W164S variant causes nephrogenic diabetes in-
sipidus (Rosenthal et al., 1992; van den Ouweland et al., 1992; 
Swanson et al., 2000). These mutations are localized in the pre-
dicted transmembrane and cytosolic segments (Fig. S5 A) and 
impair the biosynthetic processing of the respective GPCR 
(Oksche et al., 1996; Van Craenenbroeck et al., 2005). Both 
DRD4-M345T–Flag and V2R-W164S–myc displayed temper-
ature-sensitive cellular and cell surface expression defects rela-
tive to their wt counterparts in HEK293 cells as determined by 
immunoblotting and cell surface Ab binding using the extra-
cellular  Flag  and  myc  tag  of  the  DRD4  and V2R  variants,   
respectively (Fig. 7 A). The V2R-R137H harbors a minor confor-
mation defect and was expressed near the wt level (Fig. 7 A; 
Barak et al., 2001).
Remarkably, DRD4-M345T and V2R-W164S that consti-
tutively escaped the ER QC exhibited a four- to ninefold faster 
turnover rate relative to their wt counterparts at the PM (Fig. 7 B). 
Both  accelerated  internalization  and  preferential  MVB/lyso-
somal targeting account for the reduced PM residence of mutant 
GPCRs (Fig. 7, C–E). Several observations suggest that chaper-
one- and CHIP-dependent ubiquitination are responsible, at 
least in part, for the PM down-regulation of mutant GPCRs. 
(a)  The  DRD4-M345T  exhibited  increased  ubiquitination 
and CHIP binding compared with wt DRD4 as measured by de-
naturating and native cs-IP, respectively (Fig. 8 A and Fig. S5 B). 
(b) Inactivation of the E1 enzyme stabilized the mutants at the 
PM and impeded internalization in ts20 cells (Fig. S5, C and D). 
(c) Although  internalized  wt  GPCRs  were  recycled,  DRD4-
M345T and V2R-W164S were delivered into late endosomes/
lysosomes in 1 h based on FRIA (Fig. 7, D and E; and Fig. S5 E). 
Ablation of Hrs and Stam1 by shRNA compromised the lyso-
somal delivery of mutant GPCRs as indicated by their retention 
in the early endosomes of HeLa cells (Fig. 7 E). (d) The reduced 
PM stability is unlikely linked to ligand-induced activation of 
GPCRs and prolonged -arrestin-2 binding (Martin et al., 2003) 
because serum depletion failed to suppress the turnover and   
internalization rate (not depicted), and inhibiting ubiquitination 
by shCHIP (Fig. 8 B) was sufficient to attenuate internalization 
and stabilize the DRD4-M345T and V2R-W164S at the PM   
and in post-Golgi compartments (Fig. 8, C and D; and Fig. S5, 
F and G). Only the wt, but neither the catalytically inactive nor 
the TPR mutant, CHIP-myc overexpression restored the rapid 
internalization and PM turnover of the DRD4-M345T and V2R-
W164S (Fig. 8 D). These results highlight the general role of 
chaperone-dependent CHIP activity in membrane protein QC   
at the PM.
Discussion
Using  a  temperature-sensitive  model  protein  and  mutant   
GPCRs associated with conformational diseases, this work rep-
resents one of the first attempts to define some of the molecular 
constituents of the peripheral membrane protein QC that likely 
plays a fundamental role in the homeostasis of PM protein com-
position in mammalian cells.
Nonnative PM proteins are subjected to 
chaperone- and ubiquitination- 
dependent disposal
To establish a link between the conformational defect and ubiq-
uitination susceptibility of a PM protein, we constructed a CD4 
chimera containing the wt or a temperature-sensitive bacterio-
phage  domain (Parsell and Sauer, 1989). Controlled thermal 
unfolding of the CD4tl-C enabled us to isolate the ubiquitina-
tion machinery and compare the consequences of the chimera 
unfolding with that of mutant GPCRs at the cellular and bio-
chemical levels.
In addition to the temperature-sensitive biosynthetic pro-
cessing defect, we showed that the reduced PM residence time, 
accelerated internalization, and impaired recycling of unfolded 
CD4tl-C are also hallmarks of mutant V2R and DRD4 mem-
brane  trafficking.  cs-IP  of  CD4  chimeras  in  concert  with   
LC-MS/MS identified Hsp40/Hsc70/Hsp90 and CHIP as major 
components  of  the  peripheral  QC  machinery.  The  unfolded 
CD4tl-C and the DRD4-M345T ubiquitination by the chaper-
one–CHIP complex likely represents a functionally relevant QC 
mechanism of nonnative PM proteins, an inference supported by 
several observations. (a) Ablating the E1 Ub-activating enzyme 
or CHIP inhibited both ubiquitination and the rapid turnover of 
the chimera and DRD4-M345T at the PM. Although cs-IP of the 
V2R was not feasible, depletion of the E1 and CHIP also stabi-
lized  the V2R-W164S.  (b) A  similar  effect  was  observed   
by overexpressing the dominant-negative CHIP and UbH5a.   
(c) Preventing the Hsc70/Hsp90 association with the TPR domain 
of the K30A-CHIP compromised the ability of CHIP to destabi-
lize the chimera and mutant GPCRs in CHIP knockdown cells. 
(d) The unfolded rescued F508CFTR is also eliminated by   
a  chaperone-  and  CHIP-dependent  mechanism  from  the  PM 
(Okiyoneda et al., 2010).
Although we cannot rule out that nonnative PM proteins 
are directly recognized by CHIP at post-Golgi compartments 
(Rosser et al., 2007), the results are consistent with the notion JCB • VOLUME 191 • NUMBER 3 • 2010   562
Figure 6.  Lysosomal delivery of unfolded CD4tl-C is ESCRT dependent. (A) Indirect immunolocalization of internalized CD4 chimeras with transferrin (Tf) 
and LAMP2 by laser confocal fluorescence microscopy. CD4 chimeras were labeled with anti-CD4 Ab capture for 20 min at 37°C and chased in Ab-free 
medium for 1 h. Bars, 5 µm. (B–D) Luminal pH of vesicles containing endocytosed CD4 chimeras and control cargoes was measured by FRIA. Internalized 563 Protein homeostasis at the cell surface • Apaja et al.
partial unfolding of the ErbB2 kinase domain followed by the 
sequential recruitment of Hsc70/Hsp70 and Cullin5 or CHIP 
(Xu et al., 2002; Zhou et al., 2003; Jung et al., 2007; Ehrlich   
et al., 2009). Subsequent ubiquitination accounts for internal-
ization, proteasome-dependent processing, and lysosomal tar-
geting of the receptor (Lerdrup et al., 2006).
Although  CHIP  ablation  prevented  CD4  chimera  and 
DRD4 ubiquitination and restored some of their metabolic and 
PM stability, the turnover of the mutants remained faster than 
their wt counterpart. This could be attributed to residual CHIP 
activity and/or up-regulation of alternative cellular proteostatic 
mechanisms in analogy to the redundant role of Doa10, Ubr1, 
and San1 in the UPS-dependent degradation of misfolded cyto-
solic proteins in the yeast cytoplasm (Lewis and Pelham, 2009; 
Heck et al., 2010). Likewise, cytosolic substrate recognition 
could be accomplished by a chaperone-dependent function of 
Parkin, Mdm2, and Cullin5 Ub ligases, implying that multiple 
QC E3 enzymes are probably involved in misfolded PM protein 
degradation in mammalian cells (Nagata et al., 1999; Imai et al., 
2002; Ehrlich et al., 2009). In addition, autophagocytosis of 
that Hsp40/Hsc70 is recruited to exposed hydrophobic patches 
of nonnative cytosolic regions followed by CHIP–UbcH5 bind-
ing. A similar sequence of events was documented for the   
mutant CFTR ubiquitination at the ER (Meacham et al., 2001). 
We  envision  that  mutations  in  the  predicted  transmembrane   
segments of V2R and DRD4 as well as in monotopic mem-
brane proteins (Fayadat and Kopito, 2003) provoke structural 
rearrangements that lead to the cytosolic ubiquitination of 
client proteins.
CHIP activity has been recognized as an essential compo-
nent of the ER and cytosolic QC mechanisms (Murata et al., 
2001; Cyr et al., 2002; McDonough and Patterson, 2003). Our 
results highlight the role of CHIP as a QC E3 ligase in the deg-
radation of conformationally defective PM proteins that either 
have escaped the ER or are generated by environmental stress in 
situ. Down-regulation of the ErbB2 tyrosine kinase receptor 
from the PM may follow an overlapping mechanism with the 
difference that inhibition of Hsp90 activity is indispensable for 
the receptor disposal (Xu et al., 2001; Barr et al., 2008). It is as-
sumed that geldanamycin-induced Hsp90 inhibition provokes 
chimeras were labeled with anti-CD4 Ab and FITC-Fab on ice and chased for 1 h (B) or for the indicated time (C and D) at 37°C. In B, the Gaussian dis-
tribution (curved lines) and mean vesicular pH (bold numbers) are indicated. The chimera was rescued at 26°C before FRIA (D). (E) Verification of Tsg101 
(Tsg), Hrs, and Stam1 depletion in siRNA-treated cells. (F) The stability of internalized CD4tl-C, labeled by anti-CD4 Ab capture, was measured in shNT, 
shHrs, and shStam cells as described in Fig. 4 D. IB, immunoblot. (G) The mean vesicular pH of CD4tl-C and other cargoes was determined after 1-h chase 
in cells depleted for Tsg101, Hrs, and Stam1. Molecular mass is given in kilodaltons. The data shown represent means ± SEM.
 
Figure 7.  The disposal of mutant V2R and DRD4 from the PM is CHIP and ESCRT dependent. (A) Cellular (top) and PM (bottom) expression of Flag-DRD4 
and myc-V2R variants in transiently transfected HEK-293 cells. Immunoblotting and cell surface density were measured as described in Materials and 
methods. Molecular mass is given in kilodaltons. Open arrowhead, complex glycosylated forms. Closed arrowhead, core glycosylated forms. Circle, 
nonglycosylated form. (B) Turnover of GPCRs that accumulate constitutively at the PM was determined by using anti-Flag or anti-myc Ab and ELISA assay at 
37°C. (C) The internalization of DRD4s and V2Rs was measured by the Ab uptake assay. (D and E) Postendocytic sorting of DRD4 and V2R variants was 
followed by FRIA after 15–60-min chase in control, shStam-, or shHrs-expressing cells as described in Fig. 6 B. The data shown represent means ± SEM.JCB • VOLUME 191 • NUMBER 3 • 2010   564
post-Golgi compartments are not restricted to higher eukary-
otes. The conformationally impaired Pma-1 (H-ATPase) and 
general amino acid permease Gap1 are rapidly cleared from the 
cell surface via ubiquitination-dependent vacuolar degradation 
in yeast (Gong and Chang, 2001; Pizzirusso and Chang, 2004; 
Liu and Chang, 2006; Lauwers et al., 2007). In contrast, stabili-
zation of the temperature-sensitive Ura3 or -L57A cytosolic 
domains was observed upon tethering them to the PM as com-
pared with their rapid degradation at ERs (Lewis and Pelham, 
2009). Ubiquitination was also indispensable for the vacuolar 
degradation of various transporters during stress-induced re-
modeling of the yeast PM, a process mediated by ART1–9 and 
endocytic vesicles enriched in ubiquitinated cargoes (Filimonenko 
et al., 2007; Lee et al., 2007; Raiborg and Stenmark, 2009),   
proteasome-dependent  processing  of  misfolded  polypeptides 
(Ciechanover et al., 1980; Waxman et al., 1987), and/or recruit-
ment of arrestin domain–containing adaptors, the mammalian 
orthologues of arrestin-related adaptor proteins (ARTs), in con-
cert with their cognate E3 ligase can be envisioned as auxiliary 
mechanisms of the peripheral protein QC in eukaryotes (Lin   
et al., 2008; Nikko et al., 2008).
Although direct comparison of the peripheral QC effi-
ciency between mammalian and yeast cells is presently not pos-
sible, several studies suggest that proteostatic mechanisms in 
Figure 8.  CHIP-dependent ubiquitination contributes to mu-
tant V2R and DRD4 disposal from the PM. (A) Ubiquitination 
of wt and M345T-DRD4 was measured by denaturing cs-IP 
as described in Fig. 2 A using anti-Flag and P4D1 anti-Ub 
Abs. Open arrowhead, complex glycosylated form. (B) Effect 
of CHIP depletion (shCHIP) on the ubiquitination of wt and 
M345T-DRD4 at the PM as measured in A. (C) Metabolic 
stability of internalized DRD4 was determined after in vivo 
labeling with anti-Flag Ab in control and CHIP-ablated cells 
as in Fig. 4 D. (D) The impeded internalization and PM turn-
over of the M345T-DRD4 and W164S-V2R in shCHIP cells 
were reverted to the mutant phenotype by overexpressing the 
wt but not the catalytically inactive or TPR mutant CHIP-myc. 
The internalization and PM stability of GPCRs were monitored 
with cell surface ELISA. Western blots show the expression of 
CHIP-myc variants. Molecular mass is given in kilodaltons. IB, 
immunoblot. The data shown represent means ± SEM.565 Protein homeostasis at the cell surface • Apaja et al.
modification or by exposing a linear peptide-binding site for   
the E3 enzyme on either the GPCRs or their cognate adaptor   
-arrestin-2 (Shenoy et al., 2001).
Among mutant membrane proteins that are subjected to 
rapid clearance from the PM, ubiquitination of CFTR, BSEP, 
and NHE6 has been established (Plass et al., 2004; Sharma   
et al., 2004; Roxrud et al., 2009). The phenotype of certain mu-
tant BSEPs and CFTRs associated with progressive familial   
intrahepatic cholestasis type 2 disease and cystic fibrosis, re-
spectively,  suggests  that  metabolic  destabilization  correlates 
with their ubiquitination at the PM (Sharma et al., 2004; Hayashi 
and Sugiyama, 2009). The severity of cholestasis and cystic 
fibrosis is inversely proportional to the PM density of the BSEP 
and CFTR, respectively (Benharouga et al., 2001; Lam et al., 
2007). In light of the limited fidelity of the ER QC (Wang and 
Ng, 2010) and delayed unfolding of mutant polypeptides, it is 
tempting to speculate that the peripheral QC may exacerbate the 
phenotype of conformational diseases by prematurely disposing 
partially  functional  mutants  from  post-Golgi  compartments.   
Indeed, selected mutants of CFTR, MLC1 (megalencephalopathy 
leukodistrophy with subcortical cyst 1), V2R, and BSEP could 
escape the ER QC and be targeted for endolysosomal degrada-
tion from the PM in primary cells and heterologous expression 
systems (Morello et al., 2000; Sharma et al., 2004; Robben et al., 
2005; Duarri et al., 2008; Hayashi and Sugiyama, 2009).
In summary, we have provided evidence for the role of 
chaperone–CHIP and ESCRT in the recognition, ubiquitination, 
and  lysosomal  degradation  of  a  conformationally  impaired 
model protein and two mutant GPCRs from the cell surface. 
Thus, the peripheral protein QC system complements the func-
tion of established protein surveillance mechanisms of the ER, 
cytoplasm, nucleus, and mitochondria by preserving proteostasis 
at the PM and in endocytic organelles in higher eukaryotes.
Materials and methods
Plasmids, cell culture, and transfection
The wt and L57C mutation (C) of the N-terminal domain of  bacterio-
phage  (available  from  GenBank/EMBL/DDBJ  under  accession  no. 
X00166; Parsell and Sauer, 1989) were fused in frame to the C terminus 
of the CD4tl or the EGFP-C1 (Fig. 1 A) by PCR mutagenesis. The cDNA of 
the  domain was provided by B. Sauer (Massachusetts Institute of Technol-
ogy, Cambridge, MA) and A. Davidson (University of Toronto, Toronto, 
Canada). Construction of the CD4tl and CD4tl-Ub has been previously 
described (Barriere et al., 2006). The following plasmids were gifts: 
Flag-DRD4.4 was obtained from H.H. van Tol (University of Toronto; 
Van Craenenbroeck et al., 2005); myc-V2R variants, GFP
2-Ub (K48A and 
K63A), GFP
2-UbAA (K48A, K63A, G75A, and G76A), and EPAC were 
given by M. Bouvier (University of Montréal, Montréal, Canada; Terrillon 
et al., 2003; Perroy et al., 2004; Kocan et al., 2008); Nedd4 was given 
by A. Fotia (Hanson Institute, Adelaide, Australia; Fotia et al., 2006); Cbl-b 
was obtained from S. Lipkowitz (National Cancer Institute, National In-
stitutes of Health, Bethesda, MD); AIP4 was obtained from A. Marchese 
(Loyola University, Chicago, IL; Marchese et al., 2003); and UbcH5a, 
UbcH5b, and UbcH5c were given by K. Iwai (Kyoto University, Kyoto, Japan; 
Gonen et al., 1999). RlucII (Rluc T781A and F782A) was genetically fused 
to the C terminus of the CD4tl or inserted between the CD4tl and Ub or C 
by PCR mutagenesis using EPAC cDNA as a template (Fig. 2 B). Stable in-
ducible Flp-In T-Rex HEK293 cell lines expressing CD4 chimeras were gen-
erated by using the Flp-In T-Rex Core kit (Invitrogen) as previously described 
(Apaja et al., 2006) and used in most experiments if not indicated other-
wise. Transgene expression was induced in the presence of 0.5 µg/ml tetra-
cycline for 24 h at 37°C. Transient transfection of HEK293, COS7, or 
HeLa cells was performed using FuGENE 6 (Roche) or Lipofectamine 2000 
Rsp5 recruitment (Lin et al., 2008; Nikko et al., 2008; Nikko 
and Pelham, 2009). Though phosphorylation of certain trans-
porters serves as a recognition signal for ART binding (Nikko 
and Pelham, 2009), the appealing hypothesis that ARTs can   
recognize stress-induced nonspecific conformational changes 
remains to be demonstrated.
Cell surface polyubiquitination as a sorting 
signal for a nonnative PM protein
Accumulating evidence suggests that most Ub-chain configura-
tions, including K48-, K11-, and K63-linked Ub chain, are   
involved in the proteasome-mediated degradation of client 
proteins (Xu et al., 2009). Conversely, besides the K63-linked 
chain, the contribution of K11-, K29-, and K48-linked Ub 
chains has been recognized in the internalization of PM proteins 
(Chastagner et al., 2006; Varghese et al., 2008; Boname et al., 
2010). The K63-linked Ub chain was more abundant in the un-
folded CD4tl-C at the PM, whereas the ER-entrapped chimera 
and  the  EGFP-C  contained  preferentially  K48-linked  Ub 
chains. Although we cannot rule out additional differences in 
the Ub-chain configuration between the soluble and membrane-
bound C, our results are consistent with the emerging model 
that both K48- and K63-linked Ub chains can participate in 
both proteasome- and lysosomal-dependent protein degradation 
with variable efficiency (Xu et al., 2009; Boname et al., 2010). 
The escape mechanism of nonnative PM proteins from exten-
sive proteasome-dependent processing remains to be elucidated. 
Forked Ub-chain synthesis by the CHIP–UbcH5 complex (Kim 
et al., 2007) as well as complex formation with Ub-binding sort-
ing adaptors may represent some of the protective mechanisms 
against premature proteolysis.
Consistent with the diverse configurations of Ub chains 
on PM proteins, the selectivity of Ub-binding adaptors in the 
internalization and endosomal sorting machinery appears to be 
limited (Shields et al., 2009; Ren and Hurley, 2010). Both 
epsin1 and eps15 clathrin adaptors recognize the K63-linked and 
K48-linked poly-Ub chain, though the K63 chain with higher 
avidity (Barriere et al., 2006; Hawryluk et al., 2006). Likewise, 
the heterodimeric ESCRT-0 complex has only a threefold higher 
affinity to K63- than to the K48-linked poly-Ub chain (Ren and 
Hurley, 2010). This modest Ub-chain selectivity, together with 
reconfiguration of Ub chains by deubiquitinating enzymes, likely 
ensures efficient lysosomal degradation of cargoes with various 
Ub-chain topologies.
The possible role of peripheral QC 
machinery as genetic modifiers in the  
loss-of-function phenotype associated with 
mutant PM proteins
Although  the  peripheral  QC  of  the  mutant V2R  and  DRD4   
phenotypically is reminiscent of the ligand-induced desensitiza-
tion of wt GPCRs, the molecular machinery accounting for 
ubiquitination is distinct. Instead of CHIP, ligand-induced 
down-regulation of GPCR is mediated by cellular Cbl (Jacob   
et al., 2005), Mdm2 (Shenoy et al., 2001), Nedd4 (Shenoy et al., 
2008), and/or related E3 ligases, including AIP4 (Marchese et al., 
2003). These E3 enzymes are recruited by posttranslational JCB • VOLUME 191 • NUMBER 3 • 2010   566
([K
11-only]Ub)n ubiquitinylated substrate was purchased from Enzo Life Sci-
ences, Inc. K48- and K63-Ub chain–specific Apu2.07 and Apu3.A8 Abs 
(Newton et al., 2008), respectively, were provided by Genentech. P4D1 
(Santa Cruz Biotechnology, Inc.) and K63 (Enzo Life Sciences, Inc.) anti-Ub 
Abs were also used. The following heat shock protein Abs were obtained 
from Stressgen: Hsp90 (SPA839), Hsp70 (SPA810), Hsp70 (SPA815), and 
Hsp40 (SPA900). Other Abs were purchased from the following sources: 
HA  (cl11;  Covance),  HRP-Flag  (M2,  Sigma-Aldrich),  Tsg101  (GeneTex 
Inc.), GFP (Takara Bio Inc.), GFP for IP (3E6; Invitrogen), and Stam1 and 
Hrs (gift from H. Stenmark, Oslo University Hospital, Oslo, Norway). We 
used the following inhibitors: 10 µM concanamycin A (Sigma-Aldrich),   
1 µM bafilomycin A1 (LC Laboratories), 1 µM epoxomicin (EMD), 10 µM 
MG132 (Sigma-Aldrich or Cayman Chemical), and 5 µM clastolactacystin 
-lactone (Sigma-Aldrich).
Metabolic stability of CD4 chimeras and GPCRs at the cell surface and 
endocytic pathway
The cell surface stability was monitored by the cargo–Ab complex dis-
appearance from the PM. The Ab incubation, washing, and detection were 
performed as described in Cell surface density measurements of CD4 chi-
meras  and  GPCRs.  To  determine  the  PM  stability,  primary  Ab–labeled 
cargo was chased for 0–5 h at 37°C or 26°C as indicated in Fig. 1 F, and 
the remaining PM signal was measured.
Metabolic stability of the CD4tl-C and DRD4 mutant residing at 
the cell surface and in endocytic compartments was accomplished by in-
cubating cells with primary Ab on ice for 1 h and chasing the labeled 
cargo for 0 or 1 h at 37°C. Cargo–Ab complexes were isolated by non-
denaturating IP as described in the preceding paragraph and detected   
by immunoblotting.
LC-MS/MS
PM-resident protein complexes of CD4tl-C and CD4tl were isolated by   
cs-IP under native conditions as described in the preceding paragraph.   
Immunoprecipitates were bound to Dynabeads (M280, sheep anti–mouse; 
Invitrogen), washed with 50 mM ammonium bicarbonate, pH 7.8, and 
eluted with 500 mM ammonium hydroxide, pH 11. The LC-MS/MS was 
performed on the Proteomics Discovery Platform (Institute de Recherches 
Cliniques de Montréal, Montréal, Canada). The LC-MS/MS procedure has 
been described in detail by Cloutier et al. (2009). In brief, after trypsin di-
gestion of precipitates, peptides were isolated on a NanoLC-2D system 
(Eksigent) and injected into an LTQ Orbitrap (Thermo Fisher Scientific). Pro-
tein database searching was performed with Mascot 2.1 (Matrix Science) 
against the human NCBInr protein database. The mass tolerances for pre-
cursor and fragment ions were set to 10 parts per million and 0.6–0.8 D, 
respectively.  Trypsin  was  used  as  the  enzyme,  allowing  for  up  to  two 
missed cleavages. Carbamidomethyl and oxidation of methionine were al-
lowed as variable modifications. Protein identification data are derived 
from at least three separate experiments.
Internalization and recycling assay
The internalization and recycling assays were based on monitoring the 
cargo–Ab complex disappearance from the PM and exocytosis from the 
endosomal compartment, respectively. The Ab binding and detection were 
performed as described in the Cell surface density measurements of CD4 
chimeras and GPCRs section. Cargo internalization was measured by de-
termining the uptake of the primary Ab bound at 4°C and then was inter-
nalized for 5 min at 37°C as described in Barriere et al. (2006) if not 
specified otherwise. To follow recycling, the surface-bound anti-CD4 Ab 
(1:1,000; BD) was labeled with biotin-conjugated anti–mouse Fab (216–
1,806; KPL, Inc.) for 1 h on ice. CD4 chimeras were internalized for   
40 min at 37°C, and the remaining PM biotin-Fab was blocked by 10 µg/ml 
streptavidin at 0°C (Sigma-Aldrich). Recycling was activated for 10 min at 
37°C. Exocytosed CD4 Ab–chimera complexes were measured by bind-
ing HRP-NeutrAvidin at 0°C (1:1,000; Thermo Fisher Scientific) using   
Amplex red as a substrate. The nonspecific Ab background as well as the 
residual signal derived after streptavidin blocking was taken into account 
when calculating the chimera recycling efficiency.
Immunostaining and confocal microscopy
Transiently transfected COS7 or Flp-In T-Rex HEK293 cells were cultured on 
100  µg/ml  poly-l-lysine  (Sigma-Aldrich)–coated  coverslips.  Cells  were 
fixed with 4% paraformaldehyde in PBS for 10 min and blocked with PBS 
supplemented with 0.5% BSA for 1 h at room temperature. Intracellular 
antigens were visualized in fixed, permeabilized (0.05% saponin or 0.1% 
Triton X-100) cells using the indicated primary Ab: mouse monoclonal CD4 
(Invitrogen) 48 h before analysis. Cells were cultured in Dulbecco’s modi-
fied Eagle’s medium containing 10% fetal bovine serum and antibiotics.
RNA interference
siRNA SMARTpools to human CHIP (GenBank accession no. NM_005861), 
Hrs (GenBank accession no. NM_004712), Tsg101 (GenBank accession 
no. NM_006292), Stam1 (GenBank accession no. NM_003473), and 
nontarget siRNA (NT; 5-UAGCGACUAAACACAUCAA-3; GenBank ac-
cession no. D-001210-01) were purchased from Thermo Fisher Scientific. 
Flp-In T-Rex HEK293 cells were transfected two to three times with 50 nM 
siRNA using Oligofectamine (Invitrogen) in 2-d intervals. After transfection, 
the chimera expression was induced with 0.5 µg/ml tetracycline for 24 h. 
When indicated, the mutant chimera was temperature rescued at 26°C for 
24 h after tetracycline induction at 37°C.
Constitutive (pGIPZ) and inducible (pTRIPZ) lentivirus vectors encod-
ing microRNA-adapted shRNA specific for CHIP (GIPZ, V2LHS_208833), 
Stam1 (TRIPZ, V2THS_172428), and Hrs (TRIPZ, V2THS_36954) or NT 
(5-ATCTCGCTTGGGCGAGAGTAAG-3) were obtained from Thermo Fisher 
Scientific. Lentivirus was produced in HEK293 cells using the expression vector 
and packaging plasmids (psPAX2 and pMD2G) at a 4:3:1 ratio according to 
the instructions of the manufacturer in complex with FuGENE 6. The virus was 
concentrated by ultracentrifugation (Optima L-80 SW40 Ti; Beckman   
Coulter) at 27,000 rpm for 2 h at 4°C.
The parental or CD4tl-C–expressing Flp-In T-Rex HEK293 cells were 
transduced with lentivirus (5 MOI) and selected in the presence of 5 µg/ml 
puromycin to generate shCHIP- and NT shRNA–expressing cell lines. The 
methodology of preparing HeLa cell lines expressing the inducible shStam1 
or shHrs (10 MOI) was similar. Transcription of shRNA was verified by 
the expression of TurboGFP and TurboRFP (Thermo Fisher Scientific),   
respectively, using fluorescence microscopy. The knockdown efficiency of 
target proteins was determined by immunoblotting.
Cell surface density measurements of CD4 chimeras and GPCRs
The PM density of CD4 chimeras and GPCRs was determined by ELISA-
based assay. Cells were seeded on 24-well plates and incubated at 37°C 
or rescued at 26°C. Primary and secondary Abs were bound on ice in 
Ham’s F12 media containing 5% bovine serum (Invitrogen). The following 
Abs  were  used  to  detect  extracellular  epitopes:  CD4  chimeras  (mouse 
monoclonal OKT4 ascites fluid, 1:500 dilution; American Type Culture 
Collection), myc-V2Rs (mouse monoclonal anti-myc Ab, 1:1,000 dilution; 
Covance), and Flag-DRD4 (M2 anti-Flag Ab, 1:2,000 dilution; Sigma- 
Aldrich). Excess Ab was washed away, and specific binding was determined 
by HRP-conjugated secondary Ab (GE Healthcare) with Amplex red (Invit-
rogen) as a substrate. The fluorescence intensity was measured from qua-
druplicate samples using a fluorescence plate reader (POLARstar OPTIMA; 
BMG  Labtech  Inc.)  at  544-nm  excitation  and  590-nm  emission  wave-
lengths. Total Ab binding was corrected with nonspecific Ab binding as 
determined in mock-transfected cells.
IP and protein analyses
Selective isolation of CD4 chimeras and GPCRs from the PM was accom-
plished by cs-IP. CD4 chimeras and DRD4 variants were labeled with rat 
monoclonal anti-CD4 (1:2,000; AbD Serotec) and mouse monoclonal anti-
Flag  Ab  (M2,  1:2,000;  Sigma-Aldrich),  respectively,  in  tissue  culture   
medium containing 20 µM MG132, 10 µg/ml pepstatin, and 10 µg/ml   
leupeptin in living cells on ice for 1 h. Unbound Ab was washed away with 
PBS, and cells were chased for the indicated time at 37°C and solubilized 
in NP-40 lysis buffer (0.2% NP-40, 25 mM Tris-Cl, 150 mM NaCl, 10 µM 
MG132, 10 µg/ml pepstatin + leupeptin, 1 mM phenylmethylsulfonyl 
fluoride, and 5 mM N-ethylmaleimide, pH 7.4) on ice. Immunoprecipitates 
were bound to protein G agarose (20 µl of 50% slurry; Invitrogen), 
washed three times with lysis buffer, and eluted with Laemmli sample buffer 
for immunoblotting.
To monitor the ubiquitination of the PM-resident CD4 chimeras and 
DRD4s, membrane proteins were Ab labeled as described for cs-IP. Alter-
natively, for total IP, anti-CD4 Ab was added after lysis (1:2,000). Cells 
were lysed in radioimmunoprecipitation assay buffer containing 10 µM 
MG132, 10 µg/ml pepstatin + leupeptin, 1 mM phenylmethylsulfonyl 
fluoride, and 5 mM N-ethylmaleimide. CD4 chimeras and DRD4s were de-
natured in 1% SDS for 5 min at room temperature and immunoprecipitated 
after adjusting the SDS concentration to 0.1% (wt/vol) with radioimmuno-
precipitation assay buffer. Polypeptides were separated by SDS-PAGE and 
probed by immunoblotting using the Enhanced Chemiluminescence Detec-
tion system (GE Healthcare) or Western Lightning (PerkinElmer). K48- and 
K63-specific  tetra-Ub  chains  were  obtained  from  Boston  Biochem,  and 567 Protein homeostasis at the cell surface • Apaja et al.
the cellular and biochemical phenotype of the EGFP-C and the role of CHIP 
in its ubiquitination and turnover. Fig. S5 depicts the effect of the E1 enzyme 
and CHIP inactivation on the stability of mutant GPCRs and CHIP asso-
ciation with the mutant DRD4. Online supplemental material is available   
at http://www.jcb.org/cgi/content/full/jcb.201006012/DC1.
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was determined in the presence of coelenterazine 4a (Biotium) or ViviRen 
(Promega) in transiently transfected HEK293 cells (1:4 ratio, RlucII:GFP
2) 
as described in Perroy et al. (2004). Cells were suspended in 0.1%   
glucose-containing PBS, and BRET
2 signal was monitored by luminometer   
(POLARstar OPTIMA). The BRET
2 signal was calculated by determining the 
ratio of the GFP
2 fluorescence (at 500–530 nm) and the luminescence of 
the RlucII-containing proteins (at 370–450 nm). The values were corrected 
by subtracting the background signals of nontransfected cells. The non-
specific BRET
2 signal between CD4tl-RlucII-C and GFP
2 was routinely deter-
mined at a GFP
2 expression level comparable to that detected for GFP
2-Ub. 
This was accomplished by transiently transfecting HEK293 cells with in-
creasing amounts of the expression plasmid encoding the GFP
2.
Statistical analysis
Experiments were repeated at least three times, and data were expressed 
as means ± SEM. Two-tailed p-values were calculated at a 95% confidence 
level with unpaired t test using Prism software (GraphPad Software, Inc.).
Online supplemental material
Fig. S1 shows the inducible expression, stability, and internalization of CD4 
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